Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: A marginal structural model analysis

Maya L. Petersen, Yue Wang, Mark J. Van Der Laan, David Guzman, Elise Riley, David Bangsberg

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Background. Pillbox organizers are inexpensive and easily used; however, their effect on adherence to antiretroviral medications is unknown. Methods. Data were obtained from an observational cohort of 245 human immunodeficiency virus (HIV)-infected subjects who were observed from 1996 through 2000 in San Francisco, California. Adherence was the primary outcome and was measured using unannounced monthly pill counts. Plasma HIV RNA level was considered as a secondary outcome. Marginal structural models were used to estimate the effect of pillbox organizer use on adherence and viral suppression, adjusting for confounding by CD4 + T cell count, viral load, prior adherence, recreational drug use, demographic characteristics, and current and past treatment. Results. Pillbox organizer use was estimated to improve adherence by 4.1%-4.5% and was associated with a decrease in viral load of 0.34-0.37 log 10 copies/mL and a 14.2%-15.7% higher probability of achieving a viral load ≤400 copies/mL (odds ratio, 1.8-1.9). All effect estimates were statistically significant. Conclusion. Pillbox organizers appear to significantly improve adherence to antiretroviral therapy and to improve virologic suppression. We estimate that pillbox organizers may be associated with a cost of ∼$19,000 per quality-adjusted life-year. Pillbox organizers should be a standard intervention to improve adherence to antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)908-915
Number of pages8
JournalClinical Infectious Diseases
Volume45
Issue number7
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Structural Models
Viral Load
HIV
San Francisco
Quality-Adjusted Life Years
Street Drugs
CD4 Lymphocyte Count
Therapeutics
Odds Ratio
Demography
RNA
T-Lymphocytes
Costs and Cost Analysis

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression : A marginal structural model analysis. / Petersen, Maya L.; Wang, Yue; Van Der Laan, Mark J.; Guzman, David; Riley, Elise; Bangsberg, David.

In: Clinical Infectious Diseases, Vol. 45, No. 7, 2007, p. 908-915.

Research output: Contribution to journalArticle

Petersen, Maya L. ; Wang, Yue ; Van Der Laan, Mark J. ; Guzman, David ; Riley, Elise ; Bangsberg, David. / Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression : A marginal structural model analysis. In: Clinical Infectious Diseases. 2007 ; Vol. 45, No. 7. pp. 908-915.
@article{b6a146c1d1b040a0a70972ca2540f96e,
title = "Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: A marginal structural model analysis",
abstract = "Background. Pillbox organizers are inexpensive and easily used; however, their effect on adherence to antiretroviral medications is unknown. Methods. Data were obtained from an observational cohort of 245 human immunodeficiency virus (HIV)-infected subjects who were observed from 1996 through 2000 in San Francisco, California. Adherence was the primary outcome and was measured using unannounced monthly pill counts. Plasma HIV RNA level was considered as a secondary outcome. Marginal structural models were used to estimate the effect of pillbox organizer use on adherence and viral suppression, adjusting for confounding by CD4 + T cell count, viral load, prior adherence, recreational drug use, demographic characteristics, and current and past treatment. Results. Pillbox organizer use was estimated to improve adherence by 4.1{\%}-4.5{\%} and was associated with a decrease in viral load of 0.34-0.37 log 10 copies/mL and a 14.2{\%}-15.7{\%} higher probability of achieving a viral load ≤400 copies/mL (odds ratio, 1.8-1.9). All effect estimates were statistically significant. Conclusion. Pillbox organizers appear to significantly improve adherence to antiretroviral therapy and to improve virologic suppression. We estimate that pillbox organizers may be associated with a cost of ∼$19,000 per quality-adjusted life-year. Pillbox organizers should be a standard intervention to improve adherence to antiretroviral therapy.",
author = "Petersen, {Maya L.} and Yue Wang and {Van Der Laan}, {Mark J.} and David Guzman and Elise Riley and David Bangsberg",
year = "2007",
doi = "10.1086/521250",
language = "English (US)",
volume = "45",
pages = "908--915",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression

T2 - A marginal structural model analysis

AU - Petersen, Maya L.

AU - Wang, Yue

AU - Van Der Laan, Mark J.

AU - Guzman, David

AU - Riley, Elise

AU - Bangsberg, David

PY - 2007

Y1 - 2007

N2 - Background. Pillbox organizers are inexpensive and easily used; however, their effect on adherence to antiretroviral medications is unknown. Methods. Data were obtained from an observational cohort of 245 human immunodeficiency virus (HIV)-infected subjects who were observed from 1996 through 2000 in San Francisco, California. Adherence was the primary outcome and was measured using unannounced monthly pill counts. Plasma HIV RNA level was considered as a secondary outcome. Marginal structural models were used to estimate the effect of pillbox organizer use on adherence and viral suppression, adjusting for confounding by CD4 + T cell count, viral load, prior adherence, recreational drug use, demographic characteristics, and current and past treatment. Results. Pillbox organizer use was estimated to improve adherence by 4.1%-4.5% and was associated with a decrease in viral load of 0.34-0.37 log 10 copies/mL and a 14.2%-15.7% higher probability of achieving a viral load ≤400 copies/mL (odds ratio, 1.8-1.9). All effect estimates were statistically significant. Conclusion. Pillbox organizers appear to significantly improve adherence to antiretroviral therapy and to improve virologic suppression. We estimate that pillbox organizers may be associated with a cost of ∼$19,000 per quality-adjusted life-year. Pillbox organizers should be a standard intervention to improve adherence to antiretroviral therapy.

AB - Background. Pillbox organizers are inexpensive and easily used; however, their effect on adherence to antiretroviral medications is unknown. Methods. Data were obtained from an observational cohort of 245 human immunodeficiency virus (HIV)-infected subjects who were observed from 1996 through 2000 in San Francisco, California. Adherence was the primary outcome and was measured using unannounced monthly pill counts. Plasma HIV RNA level was considered as a secondary outcome. Marginal structural models were used to estimate the effect of pillbox organizer use on adherence and viral suppression, adjusting for confounding by CD4 + T cell count, viral load, prior adherence, recreational drug use, demographic characteristics, and current and past treatment. Results. Pillbox organizer use was estimated to improve adherence by 4.1%-4.5% and was associated with a decrease in viral load of 0.34-0.37 log 10 copies/mL and a 14.2%-15.7% higher probability of achieving a viral load ≤400 copies/mL (odds ratio, 1.8-1.9). All effect estimates were statistically significant. Conclusion. Pillbox organizers appear to significantly improve adherence to antiretroviral therapy and to improve virologic suppression. We estimate that pillbox organizers may be associated with a cost of ∼$19,000 per quality-adjusted life-year. Pillbox organizers should be a standard intervention to improve adherence to antiretroviral therapy.

UR - http://www.scopus.com/inward/record.url?scp=34848874182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34848874182&partnerID=8YFLogxK

U2 - 10.1086/521250

DO - 10.1086/521250

M3 - Article

C2 - 17806060

AN - SCOPUS:34848874182

VL - 45

SP - 908

EP - 915

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 7

ER -